137 related articles for article (PubMed ID: 24720680)
1. Treating hepatitis C in lower-income countries.
Jayasekera CR; Barry M; Roberts LR; Nguyen MH
N Engl J Med; 2014 May; 370(20):1869-71. PubMed ID: 24720680
[No Abstract] [Full Text] [Related]
2. [New antivirals against hepatitis C virus(protease inhibitors, polymerase inhibitors, and host factor targeting antivirals)].
Kato N; Muroyama R
Nihon Rinsho; 2011 May; 69 Suppl 4():275-81. PubMed ID: 22096931
[No Abstract] [Full Text] [Related]
3. Hepatitis C virus therapies.
Smith RE
Nat Rev Drug Discov; 2006 Sep; 5(9):715-6. PubMed ID: 17001802
[No Abstract] [Full Text] [Related]
4. Specific targeted antiviral therapy for hepatitis C.
Sulkowski MS
Curr Gastroenterol Rep; 2007 Mar; 9(1):5-13. PubMed ID: 17335672
[TBL] [Abstract][Full Text] [Related]
5. Worth the wait. New, more effective therapies for hepatitis C are on the way.
Learned J
Posit Aware; 2011; 23(1):15-8. PubMed ID: 21314021
[No Abstract] [Full Text] [Related]
6. Prompt arrival of antivirals against hepatitis C for HIV patients.
Barreiro P; Vispo E
AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
[No Abstract] [Full Text] [Related]
7. Excitement grows for potential revolution in hepatitis C virus treatment.
Opar A
Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
[No Abstract] [Full Text] [Related]
8. Treatment of hepatitis C 2010: a focus on protease inhibitors.
Lemon M
S D Med; 2010 Jun; 63(6):214-5. PubMed ID: 20853592
[No Abstract] [Full Text] [Related]
9. Infectious diseases. First specific drugs raise hopes for hepatitis C.
Enserink M
Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
[No Abstract] [Full Text] [Related]
10. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
Evans KA; Chai D; Graybill TL; Burton G; Sarisky RT; Lin-Goerke J; Johnston VK; Rivero RA
Bioorg Med Chem Lett; 2006 Apr; 16(8):2205-8. PubMed ID: 16455253
[TBL] [Abstract][Full Text] [Related]
11. A public health approach to hepatitis C control in low- and middle-income countries.
Suthar AB; Harries AD
PLoS Med; 2015 Mar; 12(3):e1001795. PubMed ID: 25757228
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic.
Thomson JA; Perni RB
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):606-17. PubMed ID: 17002221
[TBL] [Abstract][Full Text] [Related]
13. RNA dependent RNA polymerase of HCV: a potential target for the development of antiviral drugs.
Waheed Y; Bhatti A; Ashraf M
Infect Genet Evol; 2013 Mar; 14():247-57. PubMed ID: 23291407
[TBL] [Abstract][Full Text] [Related]
14. A review of HCV protease inhibitors.
Chen KX; Njoroge FG
Curr Opin Investig Drugs; 2009 Aug; 10(8):821-37. PubMed ID: 19649927
[TBL] [Abstract][Full Text] [Related]
15. New hepatitis C regimen stimulates changes in therapy management.
Reinke T
Manag Care; 2011 Dec; 20(12):41-2. PubMed ID: 22259876
[No Abstract] [Full Text] [Related]
16. The era of direct-acting antivirals has begun: the beginning of the end for HCV?
Vachon ML; Dieterich DT
Semin Liver Dis; 2011 Nov; 31(4):399-409. PubMed ID: 22189979
[TBL] [Abstract][Full Text] [Related]
17. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects.
Bartels DJ; Zhou Y; Zhang EZ; Marcial M; Byrn RA; Pfeiffer T; Tigges AM; Adiwijaya BS; Lin C; Kwong AD; Kieffer TL
J Infect Dis; 2008 Sep; 198(6):800-7. PubMed ID: 18637752
[TBL] [Abstract][Full Text] [Related]
18. Boceprevir, an NS3 protease inhibitor of HCV.
Berman K; Kwo PY
Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
[TBL] [Abstract][Full Text] [Related]
19. HCV RNA viral load assessments in the era of direct-acting antivirals.
Cobb B; Pockros PJ; Vilchez RA; Vierling JM
Am J Gastroenterol; 2013 Apr; 108(4):471-5. PubMed ID: 23552304
[TBL] [Abstract][Full Text] [Related]
20. A promising new anti-HCV protease inhibitor.
Sulkowski M
Hopkins HIV Rep; 2003 Jan; 15(1):7. PubMed ID: 12542005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
